Immunome, Inc. is an innovative biopharmaceutical company based in Exton, Pennsylvania, focused on developing breakthrough antibody therapies for oncology and infectious diseases. The company employs its proprietary platform for therapeutic antibody identification to advance a strong pipeline designed to meet significant unmet medical needs across a range of complex disease areas. By harnessing the immune system's capabilities, Immunome is poised to create transformative treatment solutions, offering an attractive investment opportunity within the dynamic biotechnology landscape for institutional investors. Show more

Location: 18702 NORTH CREEK PARKWAY, BOTHELL, WA, UNITED STATES, 98011, Bothell, WA, 98011, USA | Website: https://immunome.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

2.648B

52 Wk Range

$5.15 - $27.65

Previous Close

$24.00

Open

$24.61

Volume

1,138,396

Day Range

$24.32 - $25.76

Enterprise Value

2.645B

Cash

272.6M

Avg Qtr Burn

-40.51M

Insider Ownership

7.85%

Institutional Own.

84.20%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Varegacestat (AL102) (Gamma Secretase Inhibitor) Details Desmoid Tumors	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Varegacestat (Gamma Secretase Inhibitor) Details Desmoid Tumors	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IMM-BCP-01 Details COVID-19	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.